Avacta Group Plc (AVCT) Stock Rating Reaffirmed by FinnCap
Avacta Group Plc (LON:AVCT)‘s stock had its “corporate” rating restated by FinnCap in a research note issued on Tuesday. They currently have a GBX 200 ($2.48) price target on the stock. FinnCap’s price target would suggest a potential upside of 125.99% from the stock’s previous close.
Separately, Numis Securities Ltd reissued a “buy” rating on shares of Avacta Group Plc in a report on Monday, August 1st.
Avacta Group Plc (LON:AVCT) opened at 87.05 on Tuesday. Avacta Group Plc has a 12-month low of GBX 83.02 and a 12-month high of GBX 134.50. The stock’s market capitalization is GBX 59.44 million. The stock’s 50 day moving average price is GBX 89.99 and its 200-day moving average price is GBX 95.94.
COPYRIGHT VIOLATION WARNING: This piece of content was published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be read at http://www.dailypolitical.com/2016/11/29/avacta-group-plc-avct-stock-rating-reaffirmed-by-finncap.html.
In related news, insider Mike Owen purchased 7,763 shares of the business’s stock in a transaction dated Friday, October 21st. The stock was bought at an average cost of GBX 90 ($1.12) per share, with a total value of £6,986.70 ($8,667.29).
About Avacta Group Plc
Avacta Group plc is the developer of Affimer bio therapeutics and research reagents. The Company’s segments include Animal Health, which provides tools and contract services to assist diagnosis of conditions in animals to enable treatment for veterinarians, and Life Sciences, which provides reagents and arrays for diagnostics, drug and biomarker discovery in biotech research and development.
Receive News & Ratings for Avacta Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.